Dysregulation of c-Myc through somatic mutation, chromosomal translocation, genomic amplification or defects in upstream regulators (Albihn et al, 2010) plays a significant role in human cancer development (Couillard & Trudel, 2009; Jensen et al, 2003; Shi et al, 2009). The gene discussed is MYC; the disease is cancer.